Atlas Trials

Harvard Apparatus Regenerative Technology, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Harvard Apparatus Regenerative Technology, Inc.

RecordFirmDate
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement (NCT05877300)Harvard Apparatus Regenerative Technology, Inc.2023-07-13

Track Harvard Apparatus Regenerative Technology, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.